Table 3.
Review and comparison of previous cases with HIV/AIDS treated with extracorporeal membrane oxygenation (ECMO)
| Age (years) | Sex | New HIV diagnosis | Diagnosis | CD4 | HIV viral load (/mL) | Timing of ART initiation (pre‐, on‐, post‐ECMO) | PaO2 (mmHg)/FIO2 (%) | ECMO initiation (hospital day) | ECMO duration (days) | Outcome | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Present case | 47 | M | Yes | HIV/AIDS | 6 cells/μL | 140,000 | Post | 54.9/50 | 5 | 19 | Survived to discharge |
| Goodman4 | 30 | F | Yes | HIV/AIDS, PCP | 13 cells/mL | 976,631 | Post | 50.1/100 | 3 | 7 | Survived to discharge |
| Simpson8 | 35 | M | Yes | HIV/AIDS, PCP | NA | 1,269,866 | NA | NA/NA | NA (7 days on MV) | 27 | Survived for 6 months |
| Ali10 | 26 | M | Yes | HIV/AIDS, PCP | 84 | 907,302 | Post | 200 (P/F ratio) | NA | 6 | Survived to discharge |
| Horikita9 | 23 | M | Yes | HIV/AIDS, PCP | 8.5 cells/μL | 550,000 | On | 48/100 | NA (ICU day 3) | 12, 14 (2nd course) | Survived to discharge |
| De Rosa6 | 24 | M | Yes | HIV/AIDS, PCP | 3 cells/mm3 | 50,728 | On | 100 (P/F ratio) | 12 (6 days on MV) | 24 | Died in hospital, s/p decannulation |
| Cawcutt7 | 45 | M | Yes | HIV/AIDS, PCP | 33 cells/mL | 113,000 | Pre | 59/60 | 5 | 57 | Died in hospital, s/p decannulation |
| Gutermann2 | 55 | M | Yes | HIV/AIDS, PCP | 9 cells/mL | 80,235 | Post | NA/NA | 4 | 4 | Survived to discharge |
| Goodman4 | 25 | M | Yes | HIV/AIDS, PCP | 36 cells/mL | 622,234 | Pre | 63.6/100 | 18 | 69 | Died on ECMO |
| Steppan3 | 39 | M | NA | HIV/AIDS, PCP | 69 cells/mL | 6,297 | Pre | NA/100 | 12 | 14 | Died on ECMO |
| De Rosa6 | 21 | F | No | HIV/AIDS, PCP | 2 cells/mm3 | 118,330 | Non‐compliant, restarted | 120 (P/F ratio) | 10 | 20 | Survived to discharge |
| Simpson8 | 40 | M | No | HIV, disseminated Kaposi's sarcoma | NA | 126,947 | NA | NA | NA (1 day on MV) | 28 | Died in ICU |
| Simpson8 | 20 | F | No | HIV, adenovirus | NA | Undetectable | NA | NA | NA (1 day on MV) | 5 | Survived for 6 months |
| 25 | M | Yes | HIV/AIDS, MDR bacterial PNA | 134 cells/μL | 2,220,000 | Pre | 80/90 | 27 (11 days on MV) | 56 | Survived to discharge | |
| De Rosa6 | 38 | F | No | HIV, HCV, Legionella pneumophila | 170 cells/mm3 | 500 | Compliant and continued | 90 (P/F ratio) | 2 | 13 | Survived to discharge |
ART, antiretroviral therapy; F, female; HCV, hepatitis C virus; ICU, intensive care unit; M, male; MDR, multidrug resistant; MV, mechanical ventilation; NA, not applicable; PCP, pneumocystis pneumonia; P/F, PaO2/FiO2; s/p, status post.